DRREDDYNSEDr. Reddy's Laboratories Limited· PharmaceuticalsMediumNeutral
Announced Tue, 30 Jun · 19:36 IST

Dr Reddys files BRSR for FY26 showing ESG progress across nine principles

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.1%1-day move
₹1359.20
prior close
₹1351.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3+0.1+0.2-0.8-1.1+0.9+0.4-0.4-0.6-8.3-13.2
Up moveDown movePending
AI summary

Dr Reddy's filed its Business Responsibility and Sustainability Report for FY2026 with SEBI as required. Highlights include 50 percent cut in scope 1 and 2 emissions against 2023 baseline, 78 percent renewable electricity use, 96.7 thousand total employees and workers, 100 percent plants assessed for human rights, over 11.19 lakh individuals impacted through CSR, and zero fines for bribery or corruption. Net Zero target set for FY2045, approved by SBTi during the year.

Likely market impact

Routine SEBI-mandated ESG disclosure. Reinforces sustainability credentials and Net Zero commitments. No direct stock catalyst.